Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling.
about
Calibration methods used in cancer simulation models and suggested reporting guidelinesDevelopment, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.Alternative strategies to reduce maternal mortality in India: a cost-effectiveness analysisPopulation-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.A health services research agenda for cellular, molecular and genomic technologies in cancer care.Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.An updated natural history model of cervical cancer: derivation of model parameters.Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.Assessing health and economic outcomes of interventions to reduce pregnancy-related mortality in Nigeria.Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risksCost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparitiesApplying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran.Prophylactic HPV vaccines.Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice.Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial resultsModeling cervical cancer prevention in developed countries.A design process for using normative models in shared decision making: a case study in the context of prenatal testingCost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in IranEconomic evaluations of human papillomavirus vaccines.Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.Economic evaluation of strategies for managing women with equivocal cytological results in Brazil.Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer.Analysis of risk-structured vaccination model for the dynamics of oncogenic and warts-causing HPV types.
P2860
Q28749665-0420C758-1DFC-4452-AB56-147CB4FBE77CQ30979196-D3D6E91E-99C9-412A-B9C3-D2CBC924810FQ33565320-908A537C-981D-4009-A554-24E9832C7EDBQ33737295-7C13191A-1EB9-4DAF-ABF9-9B4F09DD84D5Q33749983-B8788849-52BA-4184-BA25-5234BDB0F1DDQ33934529-249F0C6F-7354-40B9-9D4C-731E3C801068Q34083083-8B363BBA-BC18-4E92-894F-815F10AC1BF5Q34157164-28AC8FED-F668-4F43-9C0C-C6DD57CCFAAEQ34414815-FE80B209-22C5-4DE4-9FAD-877F3922E546Q34640709-E9FDB301-C166-4A30-B412-F31C41F2993BQ34997604-B74A39D7-958C-4881-B590-46F3F65758D1Q35223397-DD6DBD94-479F-4259-A837-E9F893B8EB8BQ35484171-BAD22F82-BB39-4520-9FE2-8D6BCE2CF234Q35984558-9C39245D-EF1A-4097-819E-68EDBE7F2D88Q36322923-061198A0-D6F4-4492-BD76-5B0E0029D3E4Q36404994-B5536C58-6B3A-4997-BB81-899994355EA3Q37003878-5D856126-1DBD-4F78-828B-1CE48359EB12Q37291448-35F15CFA-B432-4FCB-B76E-F9796ABCBFF4Q37333698-5969C9CB-2A3F-4985-ACD7-0691DB4317EFQ37687207-FBDB534B-765A-4356-9E8C-A24B965ED8D0Q37763114-747540E1-3E24-4EAB-90FE-5458D98ABD8BQ37839828-F608FBD8-109C-4F50-8997-7E8E6ACF378CQ38679549-C55376CB-3924-4F99-BD04-115A76A7E5A1Q39553769-DCEF20FA-5030-429A-8BA2-372F4D540861Q40025709-D2475FE8-BC5A-4A7E-A689-8CBEF5D7C8EEQ40191017-C3C57563-A296-4B83-99A9-6AF2BD5D2456Q42205761-2FB53DEA-4BC6-4331-8FAF-B5621B4A0645
P2860
Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Chapter 18: Public health poli ...... on, and mathematical modeling.
@ast
Chapter 18: Public health poli ...... on, and mathematical modeling.
@en
type
label
Chapter 18: Public health poli ...... on, and mathematical modeling.
@ast
Chapter 18: Public health poli ...... on, and mathematical modeling.
@en
prefLabel
Chapter 18: Public health poli ...... on, and mathematical modeling.
@ast
Chapter 18: Public health poli ...... on, and mathematical modeling.
@en
P1433
P1476
Chapter 18: Public health poli ...... on, and mathematical modeling.
@en
P2093
Geoffrey P Garnett
P304
P356
10.1016/J.VACCINE.2006.05.112
P407
P478
24 Suppl 3
P577
2006-08-01T00:00:00Z